Tissue-engineered bioresorbable adhesive barrier

Project coordinator: Yulia KudryavtsevaBioTechnology LLCKemerovo, Russia

Issue

No adhesions

Solution

Tissues after surgery

Adhesive barrier

AdhesivesInflammation

Technology and novelty

Bioresorbable bio- and hemocompatible polymer

Microfibers

Anti-adhesive medications incorporated into the fibers

Adhesion prevention

CompetitorsOur product

25%

75%

Anti-adhesion product market*

Market size (2012): 0,9 bln USD

Growth rate: 14%

Market size (2018): 2.8 bln USD

* Global Industry Analysts’ Report, 2012

Commercialization scheme

BioTechnology LLCProduction cost: 50 USD/item

eSpin Technologies (USA)ISO 13485

Tailored manufacture

Raw material

Ready products

1. Research Institute (Russia)2. Maastricht University

(Netherlands)

Surgical product dealersChant-Kook (Italy)Price: 300 USD/item

Clinics

Sale Clinical trails

Investments

Financing requirement: 4 mln USD

Annual tranches in exchange for a share in the company:1st year: 0.3 mln USD for 18%2nd year: 1.7 mln USD for 16%3rd year: 2 mln USD for 15%

Tranche criteria2nd year. Experimental adhesion prevention in no less than 50% of cases. 3rd year. Successful clinical trials in Europe.

Investor’s share: up to 49%

Financial metrics

Transition to self-repayment: 3 years

IRR : 75%

NPV: 12 mln USD (discount rate: 20%)

Enterprise value after 5 years: 43 mln USD

Project length: 5 years

Project Team1. Yulia Kudryavtseva, Project Coordinator. • PhD in Biology, more than 70 scientific articles. • 1st place ‘Applied medicine’, Ekaterinburg, 2012.• ISO 13485 Certificate 2. Marina Nasonova, Researcher. 25 scientific articles.

3. Tatyana Glushkova, Researcher. 19 scientific articles.

4. Anna Bashkireva, Chief Commercial Officer.• MBA «Strategic Project Management», Moscow International Higher Business

School MIRBIS.• Expertise in international medical project management.• English: Professional, TOEFL 113.

5. Artem Galeev, Research and Innovation Specialist.• Expertise in innovational projects commercialization.• Included into the Golden Reserve of Russian Innovators (Innovator’s Advisor, 2006.

Expert Publishing)

M

M

M

B

B

Thank you for your attention and Welcome

BioTechnology LLCArtem Galeev

galeev@gmail.com

CEO & FounderYulia Kudryavtseva

Cellphone: +7 905 9026184kudrua@cardio.kem.ru

Sosnovy bulvar, 6, Kemerovo, 650002